Unless you have been under a pile of retention hyperkeratosis, it would be hard to say one has not heard the call to purposefully diversify clinical trial programs to ensure data generated is truly generalizable, let alone better appreciate demographic based nuances of disease presentation. Now how much is that happening in the OTC space you ask? Well Dr. Zoe Draelos, former AAD V.P. and Clinical Trial G.O.A.T., will answer. Press play to pick apart how clinical studies evaluating over the counter products should be structured and rewind/listen twice for good luck to learn how to purposefully recruit a diverse group of subjects and tools to make it a reality. Best practices for picking clinically relevant and meaningful outcomes – check. Can a study evaluating a cleanser and moisturizer reveal new learnings and consideration? You betcha.
Hosts: Dr. Zoe Draelos and Dr. Adam Friedman
This podcast is funded by La Roche-Posay.
Podcast: Play in new window | Download
Subscribe: RSS
